REMEDY Corrects Heterozygous Mutations Without an Exogenous Donor DNA Template

Time: 2:30 pm
day: GENE EDITING INNOVATION discussion day

Details:

• REMEDY does not require an exogenous DNA template to be provided, no AAV needed
• REMEDY can be used in numerous cell types
• REMEDY corrected multiple heterozygous mutations such as Cystic Fibrosis, VCP mutations and more

Speakers:

Meisam Kararoudi Meisam is Assistant Professor of Pediatrics, CRISPR/Gene editing Core, The Ohio State University, College of Medicine Director, and the Principal Investigator, Center for Childhood Cancer, Read more